FDA approves ORBERA balloon for obesity treatment

ORBERA Intragastric Balloon, an Apollo Endosurgery device designed to treat obesity, has earned FDA approval.

Advertisement

The ORBERA is used to assist adult patients with a body mass index of 30 to 40 in weight loss and maintenance.

“While new to the United States, ORBERA is a weight loss device with more than 220,000 balloons distributed in over 80 countries and approximately 230 published papers documenting its clinical results,” said Todd Newton, CEO of Apollo Endosurgery.

More articles on gastroenterology:
Gastro Health acquires 3 private GI practices: 5 things to know
What do gastroenterologists do to relax?
5 GI physicians in the news – Aug. 7, 2015

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.